Related Experiment Video

Updated: Aug 9, 2026

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

Expression of HECA-452 in parapsoriasis and mycosis fungoides

R Di Trolio1, G Di Lorenzo, E Barbiero

  • 1Dipartimento di Patologia Sistematica-Clinica Dermatologica, Università degli Studi di Napoli Federico II, Via Pansini 5, 80131 Naples, Italy.

International Journal of Immunopathology and Pharmacology
|March 30, 2006
PubMed

Insights

HECA-452 expression increases as parapsoriasis (PP) evolves into mycosis fungoides (MF). This biomarker may help differentiate between stable PP, evolving PP, and MF, aiding in diagnosis and prognosis.

Area of Science:

  • Dermatology
  • Immunohistochemistry
  • Cutaneous Lymphoma Research

Background:

  • Parapsoriasis (PP) and mycosis fungoides (MF) are distinct but related cutaneous T-cell lymphomas.
  • Distinguishing between stable PP and evolving PP that may progress to MF can be challenging.
  • Identifying reliable biomarkers is crucial for accurate diagnosis and patient management.

Purpose of the Study:

  • To investigate the expression of HECA-452 in patients with large plaque parapsoriasis (PP) and mycosis fungoides (MF).
  • To evaluate the potential role of HECA-452 as a biomarker in the progression of PP to MF.
  • To correlate HECA-452 levels with disease status (stable PP, evolving PP, MF).

Main Methods:

  • Histological analysis of skin specimens from 72 PP and 61 MF patients.
  • Immunohistochemical assessment of HECA-452 expression.
  • Comparison of HECA-452 levels between PP and MF groups, and between stable and evolving PP subgroups.

Main Results:

  • HECA-452 expression was significantly increased in MF compared to PP (p<0.01).
  • Evolving PP demonstrated significantly higher HECA-452 levels than stable PP (p<0.05).
  • A subset of MF patients (26/61) had a prior histological diagnosis of PP, indicating disease evolution.

Conclusions:

  • HECA-452 expression increases during the natural progression of mycosis fungoides.
  • HECA-452 serves as a potential biomarker for differentiating MF from PP.
  • Elevated HECA-452 levels may predict the evolution of PP to MF, aiding in early detection and intervention.

More Related Videos

SCAnED - An Open-source Skin Segmentation Macro for Semi-automated Cell and Nuclei Detection in Epidermal and Dermal Skin Compartments06:34

SCAnED - An Open-source Skin Segmentation Macro for Semi-automated Cell and Nuclei Detection in Epidermal and Dermal Skin Compartments

Published on: August 8, 2025

Related Concept Videos

Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...